{"id":10283,"date":"2026-05-11T14:40:23","date_gmt":"2026-05-11T14:40:23","guid":{"rendered":"https:\/\/stoxpo.com\/?p=10283"},"modified":"2026-05-11T14:40:23","modified_gmt":"2026-05-11T14:40:23","slug":"moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention","status":"publish","type":"post","link":"https:\/\/stoxpo.com\/index.php\/2026\/05\/11\/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention\/","title":{"rendered":"Moderna Shares Surge as Hantavirus Vaccine Research Gains Attention"},"content":{"rendered":"\n<h4 class=\"wp-block-heading\"><em>Biotech rally fueled by outbreak concerns, promising flu vaccine data, and potential FDA leadership changes<\/em><\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Moderna (MRNA) shares climbed sharply Monday, extending gains from last week as investors reacted to the company\u2019s growing focus on hantavirus vaccine research and encouraging progress in its broader vaccine pipeline. The stock rose more than 4% during Monday trading after surging 12% on Friday, reflecting renewed optimism surrounding the biotech company\u2019s future growth opportunities.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The rally comes as concerns increase over a recent hantavirus outbreak connected to the MV Hondius Dutch cruise ship in May 2026. Several passengers reportedly became seriously ill, with at least three deaths linked to the outbreak. According to reports, some infected individuals tested positive for the Andes strain of hantavirus, a dangerous virus transmitted primarily through exposure to infected rodents.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Moderna had already been conducting early-stage hantavirus vaccine research prior to the outbreak through a collaboration with the Vaccine Innovation Center at Korea University College of Medicine. Investors now view the research program as potentially more significant amid heightened public awareness and growing concerns about emerging infectious diseases.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The stock also benefited from positive Phase 3 results for Moderna\u2019s mRNA-1010 seasonal influenza vaccine candidate announced last week. The results strengthened confidence in the company\u2019s expanding mRNA platform beyond COVID-19 vaccines, an important strategic focus as Moderna works to diversify revenue streams and rebuild long-term growth momentum.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In addition to vaccine developments, biotech stocks broadly experienced volatility following reports that President Donald Trump may remove Food and Drug Administration Commissioner Marty Makary. Investors speculate that potential leadership changes at the FDA could lead to a more flexible regulatory environment for biotechnology and pharmaceutical companies, potentially accelerating approvals and clinical development timelines.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">While Moderna continues facing challenges tied to declining COVID-related demand, investors appear increasingly focused on the company\u2019s pipeline potential in respiratory diseases, emerging viruses, and personalized medicine. The recent stock momentum suggests Wall Street is beginning to reassess the long-term value of Moderna\u2019s mRNA technology platform as new commercial opportunities emerge across global healthcare markets.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">You might like this article:<a href=\"https:\/\/stoxpo.com\/index.php\/2026\/05\/11\/micron-delivers-record-q1-results-as-ai-memory-demand-surges\/\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\">Micron Delivers Record Q1 Results as AI Memory Demand Surges<\/mark><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Biotech rally fueled by outbreak concerns, promising flu vaccine data, and potential FDA leadership changes Moderna (MRNA) shares climbed sharply Monday, extending gains from last week as investors reacted to the company\u2019s growing focus on hantavirus vaccine research and encouraging progress in its broader vaccine pipeline. The stock rose more than 4% during Monday trading [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":1430,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jnews-multi-image_gallery":[],"jnews_single_post":[],"jnews_primary_category":[],"jnews_social_meta":[],"jnews_override_counter":[],"jnews_post_split":[],"footnotes":""},"categories":[308,361],"tags":[421,416,593,418,417],"coauthors":[454],"class_list":["post-10283","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biotechnology","category-large-cap","tag-growth","tag-movers","tag-mrna","tag-news","tag-stock-market"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Moderna Shares Surge as Hantavirus Vaccine Research Gains Attention - Stoxpo<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/stoxpo.com\/index.php\/2026\/05\/11\/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Moderna Shares Surge as Hantavirus Vaccine Research Gains Attention - Stoxpo\" \/>\n<meta property=\"og:description\" content=\"Biotech rally fueled by outbreak concerns, promising flu vaccine data, and potential FDA leadership changes Moderna (MRNA) shares climbed sharply Monday, extending gains from last week as investors reacted to the company\u2019s growing focus on hantavirus vaccine research and encouraging progress in its broader vaccine pipeline. The stock rose more than 4% during Monday trading [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/stoxpo.com\/index.php\/2026\/05\/11\/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention\/\" \/>\n<meta property=\"og:site_name\" content=\"Stoxpo\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-11T14:40:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-polina-tankilevitch-3735709-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1706\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Luca Blaumann\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Luca Blaumann\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/05\\\/11\\\/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/05\\\/11\\\/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention\\\/\"},\"author\":{\"name\":\"Luca Blaumann\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/person\\\/031a96817fc4447b1046e0a10baad806\"},\"headline\":\"Moderna Shares Surge as Hantavirus Vaccine Research Gains Attention\",\"datePublished\":\"2026-05-11T14:40:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/05\\\/11\\\/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention\\\/\"},\"wordCount\":362,\"publisher\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/05\\\/11\\\/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-polina-tankilevitch-3735709-scaled.jpg\",\"keywords\":[\"Growth\",\"Movers\",\"MRNA\",\"News\",\"Stock Market\"],\"articleSection\":[\"Biotechnology\",\"Large-Cap\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/05\\\/11\\\/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention\\\/\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/05\\\/11\\\/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention\\\/\",\"name\":\"Moderna Shares Surge as Hantavirus Vaccine Research Gains Attention - Stoxpo\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/05\\\/11\\\/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/05\\\/11\\\/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-polina-tankilevitch-3735709-scaled.jpg\",\"datePublished\":\"2026-05-11T14:40:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/05\\\/11\\\/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/05\\\/11\\\/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/05\\\/11\\\/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention\\\/#primaryimage\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-polina-tankilevitch-3735709-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-polina-tankilevitch-3735709-scaled.jpg\",\"width\":2560,\"height\":1706,\"caption\":\"chemistry\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/05\\\/11\\\/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/stoxpo.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Moderna Shares Surge as Hantavirus Vaccine Research Gains Attention\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#website\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/\",\"name\":\"Stoxpo\",\"description\":\"Stock Market &amp; Financial News\",\"publisher\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/stoxpo.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\",\"name\":\"Stoxpo\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/4q4p91-LogoMakr.png\",\"contentUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/4q4p91-LogoMakr.png\",\"width\":250,\"height\":250,\"caption\":\"Stoxpo\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/person\\\/031a96817fc4447b1046e0a10baad806\",\"name\":\"Luca Blaumann\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b7bbde6ef0582da5f93c9ff12262ea37de640f314250f9e3cfaeb37e258a563a?s=96&d=mm&r=g90dbb3a40c7379bca26d2b3dc92b368b\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b7bbde6ef0582da5f93c9ff12262ea37de640f314250f9e3cfaeb37e258a563a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b7bbde6ef0582da5f93c9ff12262ea37de640f314250f9e3cfaeb37e258a563a?s=96&d=mm&r=g\",\"caption\":\"Luca Blaumann\"},\"description\":\"Luca is a proficient stock market reporter with a passion for dissecting complex market dynamics and uncovering transformative industry developments. With years of experience in leading editorial teams and overseeing coverage of the stock market and publicly traded companies, Luca has honed the ability to translate finance jargon into easily digestible articles. For tips and inquiries, reach out to Luca at tips@stoxpo.com.\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/author\\\/luca-blaumann\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Moderna Shares Surge as Hantavirus Vaccine Research Gains Attention - Stoxpo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/stoxpo.com\/index.php\/2026\/05\/11\/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention\/","og_locale":"en_US","og_type":"article","og_title":"Moderna Shares Surge as Hantavirus Vaccine Research Gains Attention - Stoxpo","og_description":"Biotech rally fueled by outbreak concerns, promising flu vaccine data, and potential FDA leadership changes Moderna (MRNA) shares climbed sharply Monday, extending gains from last week as investors reacted to the company\u2019s growing focus on hantavirus vaccine research and encouraging progress in its broader vaccine pipeline. The stock rose more than 4% during Monday trading [&hellip;]","og_url":"https:\/\/stoxpo.com\/index.php\/2026\/05\/11\/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention\/","og_site_name":"Stoxpo","article_published_time":"2026-05-11T14:40:23+00:00","og_image":[{"width":2560,"height":1706,"url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-polina-tankilevitch-3735709-scaled.jpg","type":"image\/jpeg"}],"author":"Luca Blaumann","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Luca Blaumann","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/stoxpo.com\/index.php\/2026\/05\/11\/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention\/#article","isPartOf":{"@id":"https:\/\/stoxpo.com\/index.php\/2026\/05\/11\/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention\/"},"author":{"name":"Luca Blaumann","@id":"https:\/\/stoxpo.com\/#\/schema\/person\/031a96817fc4447b1046e0a10baad806"},"headline":"Moderna Shares Surge as Hantavirus Vaccine Research Gains Attention","datePublished":"2026-05-11T14:40:23+00:00","mainEntityOfPage":{"@id":"https:\/\/stoxpo.com\/index.php\/2026\/05\/11\/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention\/"},"wordCount":362,"publisher":{"@id":"https:\/\/stoxpo.com\/#organization"},"image":{"@id":"https:\/\/stoxpo.com\/index.php\/2026\/05\/11\/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention\/#primaryimage"},"thumbnailUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-polina-tankilevitch-3735709-scaled.jpg","keywords":["Growth","Movers","MRNA","News","Stock Market"],"articleSection":["Biotechnology","Large-Cap"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/stoxpo.com\/index.php\/2026\/05\/11\/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention\/","url":"https:\/\/stoxpo.com\/index.php\/2026\/05\/11\/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention\/","name":"Moderna Shares Surge as Hantavirus Vaccine Research Gains Attention - Stoxpo","isPartOf":{"@id":"https:\/\/stoxpo.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/stoxpo.com\/index.php\/2026\/05\/11\/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention\/#primaryimage"},"image":{"@id":"https:\/\/stoxpo.com\/index.php\/2026\/05\/11\/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention\/#primaryimage"},"thumbnailUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-polina-tankilevitch-3735709-scaled.jpg","datePublished":"2026-05-11T14:40:23+00:00","breadcrumb":{"@id":"https:\/\/stoxpo.com\/index.php\/2026\/05\/11\/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/stoxpo.com\/index.php\/2026\/05\/11\/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stoxpo.com\/index.php\/2026\/05\/11\/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention\/#primaryimage","url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-polina-tankilevitch-3735709-scaled.jpg","contentUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-polina-tankilevitch-3735709-scaled.jpg","width":2560,"height":1706,"caption":"chemistry"},{"@type":"BreadcrumbList","@id":"https:\/\/stoxpo.com\/index.php\/2026\/05\/11\/moderna-shares-surge-as-hantavirus-vaccine-research-gains-attention\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/stoxpo.com\/"},{"@type":"ListItem","position":2,"name":"Moderna Shares Surge as Hantavirus Vaccine Research Gains Attention"}]},{"@type":"WebSite","@id":"https:\/\/stoxpo.com\/#website","url":"https:\/\/stoxpo.com\/","name":"Stoxpo","description":"Stock Market &amp; Financial News","publisher":{"@id":"https:\/\/stoxpo.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/stoxpo.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/stoxpo.com\/#organization","name":"Stoxpo","url":"https:\/\/stoxpo.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stoxpo.com\/#\/schema\/logo\/image\/","url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/4q4p91-LogoMakr.png","contentUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/4q4p91-LogoMakr.png","width":250,"height":250,"caption":"Stoxpo"},"image":{"@id":"https:\/\/stoxpo.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/stoxpo.com\/#\/schema\/person\/031a96817fc4447b1046e0a10baad806","name":"Luca Blaumann","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/b7bbde6ef0582da5f93c9ff12262ea37de640f314250f9e3cfaeb37e258a563a?s=96&d=mm&r=g90dbb3a40c7379bca26d2b3dc92b368b","url":"https:\/\/secure.gravatar.com\/avatar\/b7bbde6ef0582da5f93c9ff12262ea37de640f314250f9e3cfaeb37e258a563a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b7bbde6ef0582da5f93c9ff12262ea37de640f314250f9e3cfaeb37e258a563a?s=96&d=mm&r=g","caption":"Luca Blaumann"},"description":"Luca is a proficient stock market reporter with a passion for dissecting complex market dynamics and uncovering transformative industry developments. With years of experience in leading editorial teams and overseeing coverage of the stock market and publicly traded companies, Luca has honed the ability to translate finance jargon into easily digestible articles. For tips and inquiries, reach out to Luca at tips@stoxpo.com.","url":"https:\/\/stoxpo.com\/index.php\/author\/luca-blaumann\/"}]}},"_links":{"self":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/10283","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/comments?post=10283"}],"version-history":[{"count":1,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/10283\/revisions"}],"predecessor-version":[{"id":10284,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/10283\/revisions\/10284"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media\/1430"}],"wp:attachment":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media?parent=10283"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/categories?post=10283"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/tags?post=10283"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/coauthors?post=10283"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}